Search Results - "Beschorner, Niklas"
-
1
Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors
Published in PloS one (20-12-2021)“…Adeno-associated viruses (AAV) are considered non-pathogenic in humans, and thus have been developed into powerful vector platforms for in vivo gene therapy…”
Get full text
Journal Article -
2
CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
Published in Scientific reports (03-09-2015)“…Current antiviral therapies cannot cure hepatitis B virus (HBV) infection; successful HBV eradication would require inactivation of the viral genome, which…”
Get full text
Journal Article -
3
Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity
Published in Nature biotechnology (01-04-2016)“…Excision of integrated HIV proviruses derived from most HIV-1 strains is achieved with a recombinase evolved in vitro . Current combination antiretroviral…”
Get full text
Journal Article -
4
Precise excision of HTLV-1 provirus with a designer-recombinase
Published in Molecular therapy (05-07-2023)“…The human T cell leukemia virus type 1 (HTLV-1) is a pathogenic retrovirus that persists as a provirus in the genome of infected cells and can lead to adult…”
Get full text
Journal Article -
5
Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1
Published in PloS one (08-03-2024)“…Drug-based antiretroviral therapies (ART) efficiently suppress HIV replication in humans, but the virus persists as integrated proviral reservoirs in small…”
Get full text
Journal Article -
6
Improved targeting of human CD4.sup.+ T cells by nanobody-modified AAV2 gene therapy vectors
Published in PloS one (20-12-2021)“…Adeno-associated viruses (AAV) are considered non-pathogenic in humans, and thus have been developed into powerful vector platforms for in vivo gene therapy…”
Get full text
Journal Article -
7
Improving Lentiviral Transduction of CD34 + Hematopoietic Stem and Progenitor Cells
Published in Human gene therapy. Part B. Methods (01-04-2018)“…The delivery of therapeutic genes for treatment of inherited or infectious diseases frequently requires lentiviral transduction of CD34 hematopoietic stem and…”
Get more information
Journal Article -
8
G-107 Pronounced antiviral activity of next-generation LTR-specific Tre-recombinase
Published in Journal of acquired immune deficiency syndromes (1999) (01-11-2014)Get full text
Journal Article -
9
d(GGGT)4 and r(GGGU)4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers
Published in RNA biology (01-02-2013)“…Aptamers are oligonucleotides that bind targets with high specificity and affinity. They have become important tools for biosensing, target detection, drug…”
Get full text
Journal Article -
10
G-107 Pronounced antiviral activity of next-generation LTR-specific Tre-recombinase
Published in Journal of acquired immune deficiency syndromes (1999) (01-11-2014)“…HIV-1 integrates into the host chromosome and persists as a provirus flanked by long terminal repeats (LTRs). To date, treatment regimens primarily target the…”
Get full text
Journal Article -
11
Next-generation LTR-specific Tre-recombinase targets a majority of HIV-1 isolates
Published in BMC infectious diseases (23-05-2014)Get full text
Journal Article